ABPI statement: ABPI welcomes consultation on Cancer Drugs Fund

The ABPI today welcomed the launch of the Department of Health’s public consultation on the Cancer Drugs Fund (CDF) which is intended to help NHS patients get better access to new and innovative cancer medicines and the Government’s commitment to provide additional funding of £200 million annually over the next three years.

Page Content

Dr Richard Barker, Director General of the ABPI said: “This consultation raises many important questions about how the fund will operate to ensure cancer patients receive the best available medicines. We have been considering a number of the challenges for some time now and look forward to discussing these with the Government over the coming months.”

“Some of these challenges include whether the fund should be administered at regional or national level and how to ensure that NHS cancer patients across England have a fair, timely and equal opportunity to benefit from the fund.”

“Access to cancer medicines on the NHS is generally lower than access to other medicines and lower when compared to other developed countries. This is particularly the case for new cancer medicines launched within the last five years. The cancer drug fund is an important step towards the Government's goal of providing better access to modern medicines for NHS patients.”

Get in touch

I am happy for ABPI to keep my details on file and to send me details of future ABPI work and services. ABPI will not sell your data to any third party or send you any information about products or services that ABPI has no direct connection with.